Japanese insurers and the "Solvency II effect"

Last week Eiopa reported that Japan meets the criteria for equivalence assessment under Solvency II, but with certain caveats. Kunihisa Kawasaki describes the steps Japan has taken to update its risk-based capital insurance framework but says the country can't just "cut and paste" Solvency II.


European Parliament proposes extensive changes to Omnibus II and Solvency II

Proposing a shift in the full implementation date of Solvency II to 2014 was by no means the only significant item in the draft report on Omnibus II from the Committee on Economic and Monetary Affairs, published on 27 July, as William Coatesworth and John McKenzie of Milliman explain.


Bermuda awaits Eiopa's equivalence review

Bermuda's bid for "equivalence" with Europe under Solvency II has generated regulatory moves that are similar to those in the directive. Ahead of the results of Eiopa's assessment of the island's insurance regime, Lorna Davies gauges opinion in Bermuda.


Preparing for the new ORSA requirements

Solvency standards have moved from being more retrospective to a stage where an insurer is required to know whether it has enough capital for the risks ahead. David Ingram of Willis Re and Gaurav Kapoor of MetricStream analyse the impact of the own risk and solvency assessment.


Should insurers be stressing over Eiopa's capital tests?

Eiopa's insurance stress tests have come under fire, and with Solvency II still in development are they out of date already? Lorna Davies reports.


Solvency II: to delay or not to delay?

A delay to Solvency II appears inevitable, but there are competing views as to how this should be achieved. Michael Faulkner reports on the implications of a postponement.


Bernardino: "Two-year transitional adequate for hybrid debt"

Speaking exclusively to InsuranceERM, chairman of Eiopa Gabriel Bernardino dismisses criticisms that Solvency II will damage the insurance industry but says fine tuning is needed. Michael Faulkner reports.


FSA's IMAP to target large firms

The UK authority's internal model approvals process (IMAP) is to concentrate on firms with the biggest market share, Julian Adams explained to the FSA Solvency II Conference in London yesterday. He also mapped out other stages on the route to implementation of the directive.


Insurer stress tests will "help gauge Solvency II preparedness"

But exercise is not without controversy, says Towers Watson


Aviva "concerned" at group support decision

A key element of Solvency II has been excised, says Aviva's Teddy Nyahasha